IMUNON Reports Third Quarter 2023 Financial Results and Provides a Business Update
November 14, 2023 08:00 ET
|
Imunon, Inc.
Advances Non-Viral DNA-Mediated Cancer Immunotherapy and Next-Generation Vaccine Programs, with More Potent and Durable Immunity, with Multiple Near-Term Milestones Conference Call Begins...
Celyad Oncology reports third quarter 2023 financial results and recent business highlights
November 09, 2023 01:00 ET
|
Celyad Oncology SA
Publication of data detailing the development of our microRNA (miRNA)-based multiplex shRNA approach, which allows to down-regulate several genes simultaneously, in Molecular Therapy – Nucleic...
IMUNON to Hold Third Quarter 2023 Financial Results and Business Update Conference Call on Tuesday, November 14, 2023
November 07, 2023 08:30 ET
|
Imunon, Inc.
LAWRENCEVILLE, N.J., Nov. 07, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing DNA-mediated immunotherapy and next-generation...
Coffee Holdings Co., Inc. Issues Business Update Following 2023 Annual Meeting
November 03, 2023 08:00 ET
|
Coffee Holding Co., Inc.
STATEN ISLAND, New York, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Coffee Holding Co., Inc. (Nasdaq: JVA) (the “Company”) today provided a business update following its 2023 Annual Meeting held on October...
ONWARD Schedules Webcast to Provide Third Quarter 2023 Business Update
October 11, 2023 13:43 ET
|
ONWARD Medical NV
Eindhoven, Netherlands, Oct. 11, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function, and...
DHT Holdings, Inc. Business Update
October 10, 2023 16:15 ET
|
DHT Holdings, Inc.
HAMILTON, BERMUDA, October 10, 2023 – DHT Holdings, Inc. (NYSE:DHT) (“DHT” or the “Company”) today provides the following business update: For the third quarter of 2023, the Company...
ONWARD® comunica la relazione finanziaria semestrale 2023 e provvede un aggiornamento aziendale
September 19, 2023 00:30 ET
|
ONWARD Medical
Eindhoven, Sept. 19, 2023 (GLOBE NEWSWIRE) -- IL PRESENTE COMUNICATO STAMPA CONTIENE INFORMAZIONI PRIVILEGIATE AI SENSI DELL'ARTICOLO 7, PARAGRAFO 1, DEL REGOLAMENTO EUROPEO SUGLI ABUSI DI MERCATO...
ONWARD® veröffentlicht Halbjahresergebnisse 2023 und letzte Geschäftsentwicklungen
September 19, 2023 00:30 ET
|
ONWARD Medical
Eindhoven, Sept. 19, 2023 (GLOBE NEWSWIRE) -- DIESE PRESSEMITTEILUNG ENTHÄLT INSIDERINFORMATIONEN IM SINNE VON ARTIKEL 7 ABSATZ 1 DER EUROPÄISCHEN MARKTMISSBRAUCHSVERORDNUNG (596/2014) Die...
ONWARD® publie ses résultats semestriels 2023 et fait le point sur son activité
September 19, 2023 00:30 ET
|
ONWARD Medical
Eindhoven, 19 sept. 2023 (GLOBE NEWSWIRE) -- CE COMMUNIQUÉ DE PRESSE CONTIENT DES INFORMATIONS PRIVILÉGIÉES AU SENS DE L'ARTICLE 7(1) DU RÈGLEMENT EUROPÉEN SUR LES ABUS DE MARCHÉ (596/2014) ...
ONWARD® Reports 2023 Half Year Results and Business Update
September 19, 2023 00:30 ET
|
ONWARD Medical
Eindhoven, Sept. 19, 2023 (GLOBE NEWSWIRE) -- THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) US...